Davide Massa

7PUBLICATIONS
78CO-AUTHORS
Predictive and prognostic markersTumour immunologySolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 24, 2026
Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study.

|Sep 04, 2025
Prognosis and Biological Characteristics of ER-Low Metastatic Breast Cancer: Results from a Multicenter Cohort and the TONIC Trial.

Federica Miglietta, Manon De Graaf, Claudio Vernieri

|Jul 31, 2024
Immune and gene-expression profiling in estrogen receptor low and negative early breast cancer.

Davide Massa, Claudio Vernieri, Lorenzo Nicolè

|Aug 21, 2023
Immune-Related Diarrhea and Colitis in Non-small Cell Lung Cancers: Impact of Multidisciplinary Management in a Real-World Setting.

Laura Bonanno, Martina Lorenzi, Davide Massa

|Jul 07, 2023
A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+ Breast Cancer.

Federica Miglietta, Moira Ragazzi, Bethania Fernandes

|Mar 20, 2023
Characterization of Gut Microbiome Composition in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy.

Grazia Vernaci, Edoardo Vincenzo Savarino, Ilaria Patuzzi

Pageof 2

Frequent Collaborators

6 joint publications

Maria Vittoria Dieci

6 joint publications

Valentina Guarneri

5 joint publications

Matteo Fassan

4 joint publications

Federica Miglietta